China SXT Pharmaceuticals Inc (NASDAQ:SXTC) was the target of a large decrease in short interest in July. As of July 31st, there was short interest totalling 278,900 shares, a decrease of 7.7% from the June 30th total of 302,200 shares. Based on an average trading volume of 54,900 shares, the short-interest ratio is presently 5.1 days. Approximately 3.3% of the company’s shares are short sold.
Hedge funds have recently modified their holdings of the business. Jane Street Group LLC purchased a new position in China SXT Pharmaceuticals in the 2nd quarter worth approximately $72,000. Invesco Ltd. purchased a new position in China SXT Pharmaceuticals in the 2nd quarter worth approximately $88,000. Finally, Spark Investment Management LLC purchased a new position in China SXT Pharmaceuticals in the 1st quarter worth approximately $94,000. Institutional investors and hedge funds own 0.16% of the company’s stock.
SXTC stock traded down $0.24 during mid-day trading on Thursday, reaching $2.56. The company had a trading volume of 15,100 shares, compared to its average volume of 178,104. The firm has a 50 day moving average of $2.85 and a 200 day moving average of $4.64. China SXT Pharmaceuticals has a 12 month low of $1.97 and a 12 month high of $23.35.
China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine tablets in China. It provides oral prescription drugs and supplements under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company offers its products to pharmaceutical distributors, pharmaceutical companies, pharmacies, and hospitals through sales representatives.
Recommended Story: What are different types of coverage ratios?
Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.